• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cannabis Stock Gainers And Losers From August 16, 2023

    8/16/23 5:30:09 PM ET
    $ACB
    $AGFY
    $AKAN
    $BGXX
    Medicinal Chemicals and Botanical Products
    Health Care
    Farming/Seeds/Milling
    Consumer Staples
    Get the next $ACB alert in real time by email

    GAINERS:

    • Red White & Bloom Brands (OTC:RWBYF) shares closed up 300.00% at $0.04
    • Target Group (OTC:CBDY) shares closed up 43.09% at $0.01
    • Khiron Life Sciences (OTC:KHRNF) shares closed up 36.00% at $0.02
    • Radient Technologies (OTC:RDDTF) shares closed up 31.43% at $0.00
    • RIV Capital (OTC:CNPOF) shares closed up 25.62% at $0.10
    • 4Front Ventures (OTC:FFNTF) shares closed up 20.68% at $0.10
    • 1933 Industries (OTC:TGIFF) shares closed up 18.75% at $0.01
    • CLS Holdings USA (OTC:CLSH) shares closed up 16.86% at $0.07
    • CBD Unlimited (OTC:EDXC) shares closed up 16.22% at $0.04
    • CNBX Pharmaceuticals (OTC:CNBX) shares closed up 15.65% at $0.02
    • Stem Holdings (OTC:STMH) shares closed up 15.22% at $0.01
    • LFTD Partners (OTC:LIFD) shares closed up 11.11% at $1.90
    • MGC Pharmaceuticals (OTC:MGCLF) shares closed up 10.83% at $0.00
    • SNDL (NASDAQ:SNDL) shares closed up 10.13% at $1.74
    • Psychemedics (NASDAQ:PMD) shares closed up 8.77% at $4.95
    • Bright Green (NASDAQ:BGXX) shares closed up 8.00% at $0.81
    • Global Hemp Group (OTC:GBHPF) shares closed up 7.69% at $0.00
    • OrganiGram Holdings (NASDAQ:OGI) shares closed up 7.58% at $1.42
    • Rocky Mountain High (OTC:RMHB) shares closed up 7.35% at $0.01
    • Cronos Group (NASDAQ:CRON) shares closed up 7.14% at $1.80
    • Malachite Innovations (OTC:MLCT) shares closed up 7.04% at $0.19
    • Flora Growth (NASDAQ:FLGC) shares closed up 6.70% at $2.07
    • Delivra Health Brands (OTC:DHBUF) shares closed up 5.10% at $0.01
    • Rubicon Organics (OTC:ROMJF) shares closed up 4.96% at $0.41
    • Cresco Labs (OTC:CRLBF) shares closed up 4.81% at $1.09
    • Unrivaled Brands (OTC:UNRV) shares closed up 4.60% at $0.02
    • SOL Glb Inv (OTC:SOLCF) shares closed up 4.58% at $0.13
    • Tilray Brands (NASDAQ:TLRY) shares closed up 4.37% at $2.63
    • Jushi Holdings (OTC:JUSHF) shares closed up 4.28% at $0.41
    • Decibel Cannabis Co (OTC:DBCCF) shares closed up 4.15% at $0.10
    • Avicanna (OTC:AVCNF) shares closed up 3.97% at $0.19
    • MariMed (OTC:MRMD) shares closed up 3.39% at $0.28
    • Auxly Cannabis Group (OTC:CBWTF) shares closed up 3.20% at $0.01

    LOSERS:

    • EVIO (OTC:EVIO) shares closed down 98.00% at $0.00
    • Tetra Bio Pharma (OTC:TBPMF) shares closed down 35.29% at $0.00
    • Heritage Cannabis Holding (OTC:HERTF) shares closed down 26.46% at $0.01
    • Item 9 Labs (OTC:INLB) shares closed down 23.53% at $0.01
    • Blueberries Medical (OTC:BBRRF) shares closed down 22.11% at $0.01
    • MJ Holdings (OTC:MJNE) shares closed down 21.95% at $0.02
    • GrowLife (OTC:PHOT) shares closed down 16.76% at $0.00
    • Rhinomed (OTC:RHNMF) shares closed down 16.47% at $0.06
    • CBD Of Denver (OTC:CBDD) shares closed down 14.29% at $0.00
    • Vext Science (OTC:VEXTF) shares closed down 12.53% at $0.15
    • WM Tech (NASDAQ:MAPS) shares closed down 11.50% at $1.00
    • Village Farms Intl (NASDAQ:VFF) shares closed down 11.36% at $0.82
    • Agrify (NASDAQ:AGFY) shares closed down 10.98% at $2.35
    • cbdMD (AMEX:YCBD) shares closed down 10.37% at $1.21
    • Entourage Health (OTC:ETRGF) shares closed down 10.33% at $0.01
    • Willow Biosciences (OTC:CANSF) shares closed down 9.98% at $0.05
    • Leafbuyer Techs (OTC:LBUY) shares closed down 9.87% at $0.06
    • Earth Science Tech (OTC:ETST) shares closed down 8.33% at $0.06
    • Leef Brands (OTC:LEEEF) shares closed down 7.50% at $0.02
    • Zoned Props (OTC:ZDPY) shares closed down 6.82% at $0.65
    • iAnthus Capital Hldgs (OTC:ITHUF) shares closed down 6.67% at $0.01
    • Acreage Holdings (OTC:ACRHF) shares closed down 6.35% at $0.14
    • Akanda (NASDAQ:AKAN) shares closed down 6.32% at $0.51
    • SHF Hldgs (NASDAQ:SHFS) shares closed down 6.31% at $0.47
    • Enveric Biosciences (NASDAQ:ENVB) shares closed down 5.46% at $2.25
    • InMed Pharmaceuticals (NASDAQ:INM) shares closed down 5.46% at $0.88
    • Greenlane Hldgs (NASDAQ:GNLN) shares closed down 5.31% at $0.81
    • CV Sciences (OTC:CVSI) shares closed down 5.19% at $0.04
    • MediPharm Labs (OTC:MEDIF) shares closed down 5.18% at $0.06
    • Zynerba Pharmaceuticals (NASDAQ:ZYNE) shares closed down 4.44% at $1.29
    • Skye Bioscience (OTC:SKYE) shares closed down 4.43% at $0.02
    • Aurora Cannabis (NASDAQ:ACB) shares closed down 4.40% at $0.50
    • SLANG Worldwide (OTC:SLGWF) shares closed down 4.26% at $0.03
    • Leafly Holdings (NASDAQ:LFLY) shares closed down 4.24% at $0.31
    • Incannex Healthcare (NASDAQ:IXHL) shares closed down 3.89% at $1.51
    • Cannabix Technologies (OTC:BLOZF) shares closed down 3.80% at $0.20
    • GrowGeneration (NASDAQ:GRWG) shares closed down 3.50% at $2.76
    • Trees (OTC:CANN) shares closed down 3.36% at $0.05
    • Livewire Ergogenics (OTC:LVVV) shares closed down 3.12% at $0.00
    • GreenGro Technologies (OTC:GRNH) shares closed down 3.03% at $0.00

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ACB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACB
    $AGFY
    $AKAN
    $BGXX

    CompanyDatePrice TargetRatingAnalyst
    Tilray Brands Inc.
    $TLRY
    1/27/2026Hold
    Canaccord Genuity
    Aurora Cannabis Inc.
    $ACB
    1/27/2026Buy
    Canaccord Genuity
    Organigram Global Inc.
    $OGI
    1/27/2026Buy
    Canaccord Genuity
    Cronos Group Inc.
    $CRON
    1/27/2026Buy
    Canaccord Genuity
    SNDL Inc.
    $SNDL
    9/3/2025$5.00Buy
    Alliance Global Partners
    Aurora Cannabis Inc.
    $ACB
    12/11/2024Buy
    TD Cowen
    Flora Growth Corp.
    $FLGC
    11/25/2024$4.00Buy
    Aegis Capital
    SNDL Inc.
    $SNDL
    7/17/2024Speculative Buy
    Canaccord Genuity
    More analyst ratings

    $ACB
    $AGFY
    $AKAN
    $BGXX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SNDL to Report Fourth Quarter 2025 and Full Year 2025 Financial Results on March 12, 2026

    EDMONTON, Alberta, Feb. 19, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ:SNDL, CSE:SNDL) ("SNDL") announced today that it will release its fourth quarter and full year 2025 financial results for the period ended December 31, 2025, before markets open on Thursday, March 12, 2026. Following the release of its fourth quarter results, SNDL will host a conference call and webcast at 10:00 a.m. EDT (8:00 a.m. MDT) on March 12, 2026. WEBCAST ACCESS To access the live webcast of the call, please visit the following link: https://edge.media-server.com/mmc/p/aps8jm4e ABOUT SNDL INC.  SNDL Inc. (NASDAQ:SNDL, CSE:SNDL), through its wholly owned subsidiaries, is one of the largest vertically integr

    2/19/26 4:30:00 PM ET
    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care

    Enveric Biosciences Reports EB-003 BRET Receptor Engagement Assay Data

    Proprietary assays demonstrate dual Gq and β-arrestin signaling at 5-HT₂A, pathways linked in peer-reviewed studies to antidepressant and anxiolytic effects A recent independent Nature study reports that distinct signaling pathways support mechanistic separation of therapeutic benefit from hallucinations Enveric Biosciences (NASDAQ:ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced new mechanistic data demonstrating that its lead candidate, EB-003, activates both Gq- and β-arrestin–mediated signaling downstream of the 5-HT₂A receptor. Multiple independ

    2/19/26 8:00:00 AM ET
    $ENVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Organigram Announces C$65.2 Million BAT Private Placement Investment in Connection with the Acquisition of Sanity Group

    Organigram shares priced at average C$2.72 per share representing a combination of Top-Up Rights being exercised at C$2.34/share and shares issued in connection with Sanity acquisition priced at C$3.00/share. Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), a leading global cannabis company, today announced that it has entered into a subscription agreement (the "Subscription Agreement") with BT DE Investments Inc. ( "BAT"), a wholly-owned subsidiary of British American Tobacco p.l.c. (NYSE:BTI), in connection with its previously announced proposed acquisition (the "Acquisition") of Sanity Group GmbH ("Sanity" or "Sanity Group"), including shares of Sanity ow

    2/19/26 6:00:00 AM ET
    $BTI
    $OGI
    Medicinal Chemicals and Botanical Products
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $ACB
    $AGFY
    $AKAN
    $BGXX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Hrt Financial Lp bought $40,650 worth of Class A Shares (29,036 units at $1.40) and sold $10,150 worth of Class A Shares (7,868 units at $1.29) (SEC Form 4)

    4 - AKANDA CORP. (0001888014) (Issuer)

    1/20/26 2:07:19 PM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Aiello Stephen bought $221,334 worth of shares (133,334 units at $1.66), increasing direct ownership by 25% to 668,311 units (SEC Form 4)

    4 - GrowGeneration Corp. (0001604868) (Issuer)

    9/23/25 4:00:54 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    Interim CEO Kovler Benjamin bought $36,700 worth of shares (1,000 units at $36.70), increasing direct ownership by 6% to 17,000 units (SEC Form 4)

    4 - RYTHM, Inc. (0001800637) (Issuer)

    9/3/25 4:35:48 PM ET
    $AGFY
    Farming/Seeds/Milling
    Consumer Staples

    $ACB
    $AGFY
    $AKAN
    $BGXX
    SEC Filings

    View All

    SEC Form 6-K filed by Organigram Global Inc.

    6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)

    2/20/26 4:58:07 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by SNDL Inc.

    6-K - SNDL Inc. (0001766600) (Filer)

    2/19/26 4:40:03 PM ET
    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by Organigram Global Inc.

    6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)

    2/19/26 2:21:54 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACB
    $AGFY
    $AKAN
    $BGXX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Tilray

    Canaccord Genuity initiated coverage of Tilray with a rating of Hold

    1/27/26 9:29:20 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Canaccord Genuity initiated coverage on Organigram Global

    Canaccord Genuity initiated coverage of Organigram Global with a rating of Buy

    1/27/26 9:29:20 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Canaccord Genuity initiated coverage on Cronos Group

    Canaccord Genuity initiated coverage of Cronos Group with a rating of Buy

    1/27/26 9:29:20 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    $AGFY
    $AKAN
    $BGXX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Technology Officer Griffis Sarah sold $183,326 worth of shares (271,032 units at $0.68), decreasing direct ownership by 15% to 1,528,968 units (SEC Form 4)

    4 - WM TECHNOLOGY, INC. (0001779474) (Issuer)

    2/20/26 6:51:00 PM ET
    $MAPS
    Computer Software: Prepackaged Software
    Technology

    GENERAL COUNSEL Camire Brian sold $68,458 worth of shares (101,209 units at $0.68), decreasing direct ownership by 5% to 1,741,653 units (SEC Form 4)

    4 - WM TECHNOLOGY, INC. (0001779474) (Issuer)

    2/20/26 6:49:56 PM ET
    $MAPS
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Francis Douglas sold $69,682 worth of shares (103,019 units at $0.68), decreasing direct ownership by 1% to 8,467,787 units (SEC Form 4)

    4 - WM TECHNOLOGY, INC. (0001779474) (Issuer)

    2/20/26 6:48:09 PM ET
    $MAPS
    Computer Software: Prepackaged Software
    Technology

    $ACB
    $AGFY
    $AKAN
    $BGXX
    Leadership Updates

    Live Leadership Updates

    View All

    Greenlane Appoints Jason Hitchcock as Chief Executive Officer to Advance Digital Asset Treasury Strategy

    BOCA RATON, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Greenlane Holdings, Inc. ("Greenlane" or the "Company") (NASDAQ:GNLN) today announced the appointment of Jason Hitchcock as its Chief Executive Officer, effective immediately. Mr. Hitchcock is a technology executive with over 15 years of experience building and scaling revenue engines across SaaS, blockchain infrastructure, and decentralized finance. He joins Greenlane as the Company continues to execute its Berachain-focused Digital Asset Treasury ("DAT") strategy, combining disciplined capital allocation with active ecosystem participation through validator operations, staking, and liquidity provisioning. Technology Leadership and Ent

    2/18/26 8:00:00 AM ET
    $GNLN
    Durable Goods
    Consumer Discretionary

    Breckenridge Distillery Appoints Romano Beverage for Distribution in Illinois

    BRECKENRIDGE, Colo., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand owned by Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), has announced appointment of Romano Beverage, a respected partner, to manage distribution responsibilities within the state. Romano Beverage, a trusted leader in beverage distribution, is now overseeing Breckenridge Distillery's full spirits collection across Illinois—including its celebrated bourbon whiskey, whiskey, rum, vodka, gin, and newly launched Mountain Shot. Romano's strong presence in Illinois and dedication to exceptional service make them the perfect partner to help Breckenridge Distillery thr

    2/4/26 8:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    WM Technology, Inc. Appoints Harry DeMott and Brent Cox to Board of Directors and Announces Executive Employment Arrangement with CFO Susan Echard

    WM Technology, Inc. ("WM Technology" or the "Company") (NASDAQ:MAPS), a leading marketplace and technology solutions provider to the cannabis industry, today announced the appointment of Harry DeMott and Brent Cox to the Company's Board of Directors, effective February 1, 2026. The Company also announced that Susan Echard will continue to serve as Chief Financial Officer, transitioning from a contracted arrangement to employment with the Company, effective January 30, 2026. "We are pleased to welcome Harry and Brent to WM Technology's Board of Directors. They each bring a combination of cannabis industry perspective, technology fluency, and disciplined capital markets experience," said Do

    2/3/26 5:45:00 PM ET
    $ISPR
    $MAPS
    Medicinal Chemicals and Botanical Products
    Health Care
    Computer Software: Prepackaged Software
    Technology

    $ACB
    $AGFY
    $AKAN
    $BGXX
    Financials

    Live finance-specific insights

    View All

    SNDL to Report Fourth Quarter 2025 and Full Year 2025 Financial Results on March 12, 2026

    EDMONTON, Alberta, Feb. 19, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ:SNDL, CSE:SNDL) ("SNDL") announced today that it will release its fourth quarter and full year 2025 financial results for the period ended December 31, 2025, before markets open on Thursday, March 12, 2026. Following the release of its fourth quarter results, SNDL will host a conference call and webcast at 10:00 a.m. EDT (8:00 a.m. MDT) on March 12, 2026. WEBCAST ACCESS To access the live webcast of the call, please visit the following link: https://edge.media-server.com/mmc/p/aps8jm4e ABOUT SNDL INC.  SNDL Inc. (NASDAQ:SNDL, CSE:SNDL), through its wholly owned subsidiaries, is one of the largest vertically integr

    2/19/26 4:30:00 PM ET
    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care

    cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026

    CHARLOTTE, N.C., Feb. 17, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD, Bluebird Botanicals, Paw CBD, along with its THC beverage brand Oasis today announced its financial results for the first quarter of fiscal year ended December 31, 2025. cbdMD reported 12% sequential revenue growth and improved liquidity in the first quarter of fiscal 2026, reflecting continued stabilization of the core business and early benefits from recent strategic actions."We a

    2/17/26 4:10:00 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results

    CHARLOTTE, N.C., Feb. 12, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Tuesday, February 17, 2026, to discuss the company's December 31, 2025 first quarter financial results and business progress. CONFERENCE CALL DETAILS Tuesday, February 17, 2026, 4:20 p.m. Eastern Time USA/Canada: 888-880-3330 Webcast/Webcast Replay link - available through February 17, 2027: https://app.webinar.net/YzX7D4ynvN2 About cbdMD, Inc.

    2/12/26 5:31:00 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    $ACB
    $AGFY
    $AKAN
    $BGXX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:02:53 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:01:40 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Psychemedics Corporation

    SC 13D/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/12/24 5:15:40 PM ET
    $PMD
    Medical Specialities
    Health Care